← SynDRA
RELEBACTAM ANHYDROUS
SynDRA canonical compound SYN0037815 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Mechanism of action | beta lactamase inhibitor |
|---|
All known targets
- KPC-2
- L2camp
- Stap-coc blaZ
- ampC
- bla
- blaCTX-M-15
- blaKPC-4
Mechanisms of action (all sources)
- beta lactamase inhibitor
- Inhibitor
- blaCTX-M-15 INHIBITOR
- L2camp INHIBITOR
- KPC-2 INHIBITOR
- bla INHIBITOR
- blaKPC-4 INHIBITOR
Drug classes
- Anti-Bacterial Agents
- Anti-Infective Agents
- beta-Lactamase Inhibitors
- Enzyme Inhibitors
ATC classes
- OTHER BETA-LACTAM ANTIBACTERIALS
Cross-references
Synonyms
- relebactam
- recarbrio
- (-)-relebactam anhydrous
- Mk-7655
- MK 7655
- Relebactam
- UNII-1OQF7TT3PF
- 1OQF7TT3PF
- CHEMBL3112741
- Sulfuric acid, mono[(1R,2S,5R)-7-oxo-2-[(4-piperidinylamino)carbonyl]-1,6-diazabicyclo[3.2.1]oct-6-yl] ester
- Relebactam [INN]
- MK7655
- (-)-Relebactam anhydrous
- BDBM1858
- SCHEMBL3721178
- EX-A864
- SMOBCLHAZXOKDQ-ZJUUUORDSA-N
- MolPort-044-723-879
- MK-7655A
- ZINC43206319
- BDBM50447651
- AKOS027338697
- SB16968
- DB12377
- CS-5391
- Sulfuric acid mono-((2S,5R)-7-oxo-2-(piperidin-4-ylcarbamoyl)-1,6-diaza-bicyclo(3.2.1)oct-6-yl) est
- RELEBACTAM
- RECARBRIO COMPONENT RELEBACTAM
- MK-7655A COMPONENT RELEBACTAM
- relebactamum
- RECARBRIO COMPONENT RELEBACTAM MONOHYDRATE
- RefChem:879223
- DTXCID501513269
- (-)-relebactam monohydrate
- MK-7655 MONOHYDRATE
- Y1MYA2UHFL
- MFCD28502833
- Relebactam?
- Relebactam (Standard)
Reported adverse events
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Headache
- Nausea
- Rash
- Seizure
- Vomiting
- Blood creatinine
- Blood creatinine increased
- Constipation
- Death
- Hypersensitivity
Look up RELEBACTAM ANHYDROUS in the interactive SynDRA portal →